A Phase 1 Study to Evaluate the Pharmacokinetics of Roxadustat in Subjects With Different Degrees of Renal Function
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Roxadustat (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Europe Ltd
- 25 Jan 2018 Status changed from recruiting to completed.
- 20 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
- 20 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.